Bridging the Gap Between Biologics & Compliance. Grant Funds Provided by Continuing Nursing Education Credit Provided by.

Slides:



Advertisements
Similar presentations
HIV Drug Resistance Training
Advertisements

Purchasing and Inventory
Sustainability Implementing Sustainable Practices for Productivity Enhancement for Productivity Enhancement Presented by Ryte Byte, Inc.
Regulatory Challenges in the Cell Preparation Facility Adrian Gee Center for Cell & Gene Therapy Regulatory Challenges in the Cell Preparation Facility.
World Health Organization
Diane Wilson, RN Community Tissue Services
25 TAC Quality Assurance in a licensed ASC
Americas Technical Advisory Group ICCBBA ISBT 128 Blood Product Labeling – A Hospital Perspective Americas Technical Advisory Group ICCBBA.
Standar-standar yang melibatkan radiologi
Quality control of raw materials In-process control
QUALITY ASSURANCE IN BLOOD BANKING
FDA Basics: Tissue Safety
CBER Irradiated Blood Components Jennifer Jones Consumer Safety Officer CBER, OBRR, DBA September 16, 2009.
I mplant M anagement: The Importance of Tracking and Tracing All Implants, with a Focus on Human Tissue.
Clinical Pharmacy’s Role in Research Trials Sheree Miller Pharm.D. Investigational Drug Service University of Washington Medical Center.
Management of the Tuberculosis Drug Supply Module 13 – March 2010.
4. Quality Management System (QMS)
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
4. Quality Management System (QMS)
QUALITY ASSURANCE Shree Baboolal 12 th February, 2005.
Capability Cliff Notes Series PHEP Capability 9—Medical Materiel Management and Distribution What Is It And How Will We Measure It?
Patient Safety Initiatives Kelly Cronin Director, Patient Safety and Outcomes Research Office of Policy and Planning Office of the Commissioner FDA.
BRC Food Safety Quality Management System Training Guide
World Health Organization
HA Lions Eye Bank Galen Chow HKEH QA Forum HKE QA Forum 2012 Acknowledgements Dr Victoria Wong Ms Janice Wong Ms Jessie Ng Ms Jenny Yeung All the.
Recommended by the Sentinel Event Alert Advisory Group NATIONAL PATIENT SAFETY GOALS FY 2009.
JCAHO UPDATE June The Bureau of Primary Health Care is continuing to encourage Community Health Centers to be JCAHO accredited. JCAHO’s new focus.
1 ISBT-128: It’s Finally Happening! KABB Spring Meeting March 10, 2007 Debra Bowman, MT(ASCP)SBB Quality Assurance Director Kentucky Blood Center.
CBER 1 Establishment Submissions Rosia E. Nesbitt, BS, SBB(ASCP), CQA(ASQ) Consumer Safety Officer CBER, OBRR, DBA September 15, 2009.
February 2007 Commercial Vehicle Drivers Hours of Service Module 24: Daily Log Audits.
Support Programs version 2 March 2010 Cleaning and Sanitation
Top Healthcare Industry Issues
2011 NPMA Conference Series III National Capital Area Conference Leaders in Asset Management National Capitol Area Conference Charles L. Robinson, Director.
FSC402H FORENSIC SCIENCE AND THE EXPERT December 2, 2003.
IN THE NAME OF GOD Quality Assurance and Blood Bank S. AMINI KAFI ABAD CLINICAL AND ANATOMICAL PATHOLOGIST IRANIAN BLOOD TRANSFUSION ORGANIZATION(IBTO)
Leukocyte-Reduced Blood Components Lore Fields MT(ASCP)SBB Consumer Safety Officer, DBA, OBRR, CBER September 16, 2009.
Tissue Transplantation Services: Coming into Compliance Phillip J. DeChristopher, MD, PhD, Chair Anne Link, MT(ASCP), Tissue Coordinator Meg Kim, RN, OR.
Developing Policy and Procedure Management System إعداد برنامج سياسات وإجراءات العمل 8 Safar February 2007 HERA GENERAL HOSPITAL.
Dispensary and Administration Site Information Presentation.
Barcode Technology in healthcare Nowadays, published reports illustrate high rates of medical error (adverse events) and the increasing costs of healthcare.
Realtime Results Product Recall Services Effective Contact Centers / Efficient Recall Services Prepared by: Realtime Results 2054 Westport Center Drive.
An introduction to records management at Clemson University Records Center is located at the Library Depot 103 Clemson Research Blvd Anderson, S.C
IP Accountability in Outpatient Clinical Trials
Storage of Pharmaceutical Products Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University.
DENSO Supplier Labeling Policy
Informatics Technologies for Patient Safety Presented by Moira Jean Healey.
Laboratory equipment Dr. W. Huisman Cairo, November 21th 2012.
Storage, Labeling, Controlled Medications Guidance Training CFR § (b)(2)(3)(d)(e) F431.
Medication distribution
QC,QA and QSE, huh? What does it all mean?.
Tissue Management Using SoftBank
Inventory Management Chapter 13.
Integrated Supply chain management using RFID
The Joint Commission’s National Patient Safety Goals
Quality Control and Assurance
Overview of Quality Assurance
Presented by: BeeLinda L. Temple CPhT
Health Supply Chain Management: Session 6: Facilities, Staffing and Procurement Ghana Nursing Schools.
Jessica Tagerman, Pharmd, rph
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Operations and Safety Committee
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Resource Management 3.03 Understand support services
Controlled Substances
Presentation transcript:

Bridging the Gap Between Biologics & Compliance

Grant Funds Provided by Continuing Nursing Education Credit Provided by

Objectives  Define biologics  Describe the regulations & standards related to biologics  Discuss problem prone areas associated with tissue management in the OR setting  Discuss best practices for tissue management

Defining Biologics  Autograft  Allograft  Xenograft  Synthetics  Recombinant Human Growth Factors Bioengineered Grafts – biologic tissue that is combined with synthetic material for implantation

Regulations and Standards

 Center for Biologics and Research (CBER) - Requirements for human tissue banks (HCT/Ps) ◦ HCT/Ps are Human Cellular and Tissue Based-Products - Must register w/ the FDA (2001) - Requirements for donor suitability - Must follow the Good Tissue Practices (2005) ◦ Rules for record keeping ◦ Authority for FDA to inspect tissue banks ◦ Ability to recall or destroy tissue  Medical Devices…..510(k), PMA U.S. Food & Drug Administration

American Association of Tissue Banks (AATB)  Voluntary accreditation of human tissue banks  Three areas of accreditation - Retrieval - Processing - Storage/Distribution 

The Joint Commission (TJC) Transplant Safety  Voluntary accreditation of hospitals and ASCs  Apply to human and nonhuman cellular based transplantable & implantable products - Tissues (allograft & autograft) - Medical devices (allograft & xenograft)  Three areas of focus: - Standardized procedures to acquire, store, and issue tissue - Tissue tracking - Investigating adverse events

 Guidelines for utilization of human tissue in the surgical setting  Recommendations for establishing an optimal level of practice as it relates to allograft tissue  Synthesized recommendations of FDA, AATB and The Joint Commission AORN: Recommended Practices for Surgical Tissue Banking

American Association of Blood Banks (AABB)  Created to assist hospitals in the transition toward centralizing tissue banks and services within blood banks and transfusion centers in the hospital  Utilizes TJC standards as a guide

Problem Areas in Tissue Management  Receipt  Storage  Tissue Handling  Other

Receipt  Date & time  Tissue description  Tissue serial number  Expiration date  Verification - Recommended temp - Integrity of package - Bar code/serial numbers are accurate  Personnel receiving and verifying tissue JC Standards: Transplant Safety TS , EP 6,7 JC Standards: Transplant Safety TS EP 3

Receipt  Is the temperature acceptable? - Residual Coolant ◦ e.g. dry/wet ice  Validated shipping container - Documentation from supplier - Within validated timeframe  Package Integrity - Seal intact - No physical damage - Labels/barcodes are present

Vendors  Distributors of tissue must register annually with the FDA  Some states require licensure  TJC requires healthcare facilities to verify registration & licensure  Reps carrying allograft into the OR may be a violation of this requirement - Documentation of registration - Documentation of receipt of tissue

Storage  Monitoring and recording  Automated delivery  Freezer maintenance

Monitoring & Recording Requirements  Maintain daily storage logs for freeze-dried tissues requiring a controlled environment  Continuously monitor the temperature of freezers & refrigerators - Record at least daily  Ensure that all storage equipment has functioning alarms - Alarm to area manned 24/7 JC Standards: Transplant Safety (TS , TS , TS ) AORN Recommended Practices for Surgical TB. AORN Journal, February AABB Guidelines for Managing Tissue Allografts in Hospitals

Handling  Check graft & package - Integrity - Expiration date  Use aseptic technique  Follow instructions on package insert

Handling  Who handled? - Dates, times & staff  How prepared? - Per manufacturer’s instructions - Save instructions  Solutions used? - Lot # and expiration  Include in patient’s medical record - Tissue type, unique identifiers  Return tissue tracking forms to allograft tissue bank

Record Keeping  All records must be stored for minimum of ten years, but may be longer in your state, including: – Tissue supplier – Original numeric or alpha-numeric donor and lot identifiers – Recipient name or the final disposition of each tissue – The expiration dates of all tissues  All tissue usage information cards are completed and returned to the tissue supplier JC Standards: Transplant Safety (revised TS ) AORN Recommended Practices for Surgical TB. AORN Journal, February 2006.

Transporting Between Facilities  FDA registration as a tissue bank is imperative to distribute tissue to another facility  Exceptions - Facilities that are physically adjacent within the same healthcare organization

Recalls & Adverse Events  Must be able to trace the tissue - From the donor to the recipient - From the recipient to the donor  Report adverse events to supplier and possibly FDA  The Joint Commission requires a policy  For more information: - FDA Current Good Tissue Practices, AABB Guidelines for Managing Tissue Allografts in Hospitals, Steelman & Schlueter (2007). Managing a tissue recall in a large academic hospital. Transfusion. 47(5):

Top Three Concerns: TJC 1.Verification of tissue source facilities - FDA registration & state licensure 2.Verification of package upon receipt - Documentation required 3.Temperature recording & monitoring - Recording daily for ambient and refrigerated tissue - Continuous temperature monitoring for freezers & refrigerators ◦ Continuous recording is not required

Algorithm for Tissue Management  Define responsibility  Develop a team  Identify all biologics used  Map the process, “Standardize”  Review the requirements  Create a policy

Bridging the Gap  Every Joint Commission accredited facility MUST have a tissue policy  Goal is to standardize tissue management within all areas of the facility  Test by tracking serial numbers / patient implants  Adverse Events  Documentation is the most important piece of this process

Tissue Tracking Options  Manual data capture and recording - Hand written paper forms - Excel Spreadsheets - Forms from tissue bank  Automated data capture in automated system - Data transfer or bar coding - Tracking and data storage in automated platform

Manual Paper Tracking  Inconsistent staff participation  Hand written data can be difficult to track - Legibility - Searching for old data - Conducting a tissue recall (6 mo. vs. 2 min.)  Stickers or barcode labels can improve accuracy - May fall off manual sheets  Multiple staff involvement  Backing up data  Errors

Does not burden hospital IT department Utilizes barcodes, scanners, RFID tracking Integrates with existing health information system Prompts for expiring tissue and performs inventory reconciliation Tracks allograft, autograft and non-tissue items Traces product through final disposition Adverse event and recall tracking system Automatically completes tissue usage forms The “Ideal” Tracking Option

Automated Tracking  Real-time  Web-based, automated  Manage and track tissue receipt, transfer, issuance, validation, implantation or disposal  Monitor every person that interacts with the tissue  Most systems allow hospital-specific customization and real-time access from any location within the facility

Automated Tracking: Time Savings  May allow self-population of data with a barcode scan  Implantation data transferred electronically to the tissue supplier  Instant identification of all tissue inventory by serial number, code, or type

Automated Tracking: Cost Savings  May prevent the use of expired tissue through a notification system  Ordering process is streamlined with the facility-established inventory levels  Labor hours are significantly reduced with automated tracking versus paper tools  Assist with rotation of inventory and notifications for inventory that is about to expire

Automated Tracking: Compliance  Automatic tracking from purchasing through implantation  Reports are simplified and customized  Recalls conducted efficiently and completely  Ideal tracking systems will update their platform as The Joint Commission and FDA requirements change

Any Questions?

Evaluation / Registration Please remember… Complete your registration and evaluation forms in the back of your booklet Return them to your presenter